JPH04270296A - Mineral absorbefacient and production of phytic acid partial hydrolyzate or its metallic salt - Google Patents

Mineral absorbefacient and production of phytic acid partial hydrolyzate or its metallic salt

Info

Publication number
JPH04270296A
JPH04270296A JP5038491A JP5038491A JPH04270296A JP H04270296 A JPH04270296 A JP H04270296A JP 5038491 A JP5038491 A JP 5038491A JP 5038491 A JP5038491 A JP 5038491A JP H04270296 A JPH04270296 A JP H04270296A
Authority
JP
Japan
Prior art keywords
phytic acid
calcium
metal salt
salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5038491A
Other languages
Japanese (ja)
Other versions
JP2509824B2 (en
Inventor
Masami Hoshino
正美 星野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3050384A priority Critical patent/JP2509824B2/en
Publication of JPH04270296A publication Critical patent/JPH04270296A/en
Application granted granted Critical
Publication of JP2509824B2 publication Critical patent/JP2509824B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain an absorbefacient capable of promoting absorption of minerals including ingested calcium without being digested by gastric juice or intestinal juice at a low cost. CONSTITUTION:A mineral absorbefacient containing a partial hydrolyzate of phytic acid in which the number of phosphate radicals of phytic acid or its salts is at least <=5, preferably >=2.2 to <=5 or its metallic salt as a principal ingredient. The aforementioned partial hydrolyzate of the phytic acid or its metallic salt which is the principal ingredient of the mineral absorbefacient is produced by hydrolyzing the phytic acid or its salts with phytase or an inorganic acid, and stopping the hydrolysis within a range so as not to liberate all the phosphate radicals.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は食品中あるいは食品に添
加したカルシュウムその他のミネラルの吸収を促進する
ミネラル吸収促進剤、及びミネラル吸収促進剤の主成分
を成すフィチン酸部分分解物又はその金属塩の製造方法
に関する。
[Industrial Application Field] The present invention relates to a mineral absorption enhancer that promotes the absorption of calcium and other minerals contained in or added to food, and a partially decomposed product of phytic acid or its metal salt, which is the main component of the mineral absorption enhancer. Relating to a manufacturing method.

【0002】0002

【従来の技術】近年、児童の骨折事故の多発を始めとし
て老齢者の骨粗鬆症まで、カルシュウム不足は社会問題
化しつつある。去る平成2年2月に厚生省がまとめた1
988年度国民栄養調査でもカルシュウムの摂取量は年
々下降傾向が続いているのが認められ、調査した13種
類の栄養素のうち唯一不足しており、カルシウムの摂取
必要量 604mgに対して摂取量が 524mgと大
きく不足している。また、鉄に関しては摂取量が足りて
いるように見えるが、若い女性に貧血が多いとの報告が
数多くなされている。更に、鉄の摂取が一番必要な女子
学生や成人女子に鉄の摂取量不足が目立つとの調査報告
がなされている(日本栄養食糧学会昭和59年度発表;
日本人の無機質摂取量:京都大学医学部衛生学:木村恵
美子ら)、(同学会発表;成人女子の鉄栄養状態に及ぼ
す鉄摂取量の影響:日医大・生化:後藤久美子ら)。こ
のため、アメリカの第10回RDAや、日本の機能性食
品検討部会においてミネラルは最近脚光を浴びており、
それを反映して市場にもミネラル食品が多種類発売され
ている。
BACKGROUND OF THE INVENTION In recent years, calcium deficiency has become a social problem, from frequent fractures in children to osteoporosis in the elderly. 1 compiled by the Ministry of Health and Welfare in February 1990
In the 1988 National Nutrition Survey, it was recognized that the intake of calcium continues to decline year by year, and it is the only nutrient that is deficient out of the 13 nutrients surveyed, with an intake of 524 mg compared to the required intake of 604 mg. There is a big shortage. Furthermore, although it appears that iron intake is sufficient, there have been many reports that young women are more likely to be anemic. Furthermore, research reports have shown that female students and adult women, who are most in need of iron intake, are noticeably lacking in iron intake (published by the Japanese Society of Nutrition and Food Science in 1981).
Mineral intake in Japanese people: Kyoto University School of Medicine, Department of Hygiene, Emiko Kimura et al.), (presented at the same conference; Effect of iron intake on the iron nutritional status of adult women: Nichi Medical University, Biochemistry: Kumiko Goto et al.). For this reason, minerals have recently been in the spotlight at the 10th RDA in the United States and the Functional Food Study Group in Japan.
Reflecting this, many types of mineral foods are now on the market.

【0003】しかし、これらのミネラルは難吸収性であ
ることに問題があった。たとえば、カルシュウムの吸収
率は約30%であり、老齢者では15%位との報告もな
されている。鉄にいたっては通常の状態で約5%、ヘム
鉄では約25%の吸収率である。ある特定のミネラルの
吸収率が低い場合、そのミネラルの補給量を大量にすれ
ば低い吸収率を補うことができると考えられるが、1種
類の成分が多量に存在すると却って他のミネラルの吸収
率を下げてしまい、微量ミネラルの欠乏状態を起こす可
能性があることが指摘されている。さらに大量のミネラ
ルは消化器官に影響を与える。このような観点から、摂
取したカルシュウムを効率良く吸収することが自然で健
康にも望ましいと言える。従って、この目的で食品に添
加して使用できる吸収促進剤があれば極めて有用である
However, there is a problem in that these minerals are difficult to absorb. For example, the absorption rate of calcium is about 30%, and it has been reported that it is about 15% in elderly people. The absorption rate of iron is about 5% under normal conditions, and the absorption rate of heme iron is about 25%. If the absorption rate of a certain mineral is low, it may be possible to compensate for the low absorption rate by supplementing a large amount of that mineral, but if one type of mineral is present in large amounts, the absorption rate of other minerals will actually decrease. It has been pointed out that there is a possibility that this may cause a trace mineral deficiency. Additionally, large amounts of minerals affect the digestive system. From this point of view, it can be said that it is natural and desirable for health to efficiently absorb ingested calcium. Therefore, it would be extremely useful if there were an absorption enhancer that could be added to foods for this purpose.

【0004】既存のカルシュウム吸収促進剤としては、
乳蛋白の一部であるカゼインホスホペプチド(CPP)
が開発され、このCPPを含む飲料も開発され市販され
ている。牛乳や乳製品に含まれるカルシュウムの吸収効
率が良いのは、CPPの作用によるらしい事が分かって
いる(日本農化大会昭和55年度シンポジウム;食餌由
来の腸管内マクロペプチドの意義:カゼインホスホペプ
チド、東大農化、内藤博)、(日本農化大会昭和55年
度発表;ラット小腸下部におけるCa吸収におよぼすカ
ゼイン食の影響、東大農化、李連淑,野口忠,内藤博)
他。
[0004] Existing calcium absorption enhancers include:
Casein phosphopeptide (CPP), a part of milk protein
has been developed, and beverages containing this CPP have also been developed and are commercially available. It is known that the absorption efficiency of calcium contained in milk and dairy products is likely to be due to the action of CPP (Japan Agricultural Chemical Conference 1981 Symposium; Significance of dietary-derived intestinal macropeptides: casein phosphopeptides, Agricultural Science, University of Tokyo, Hiroshi Naito), (Japan Agricultural Science Conference 1981; Effect of casein diet on Ca absorption in the lower small intestine of rats, Agricultural Science, University of Tokyo, Lee Lien-suk, Tadashi Noguchi, Hiroshi Naito)
other.

【0005】CPPはカゼイン全蛋白中の約22%を占
める蛋白質(β−カゼイン)の末端側の4つのホスホセ
リン(リン酸ラジカルを各1個有する)を含んでいるア
ミノ酸20程度のペプチドである(日本食糧栄養学会昭
和60年度発表;ラット小腸内カゼインホスホペプチド
の同定とCa,Fe 可溶化能の検討、東大農化、佐藤
隆一郎,野口忠,内藤博)。一方、このβ−カゼインの
分子量は2〜3万であり、カゼインから得られるCPP
は約50分の1に過ぎない。従って、カゼインよりCP
Pを製造する場合、残りの成分の処分利用が問題となる
。また、カゼイン自身動物の乳から分離される蛋白質で
ある。これらの事によりCPPはかなり高価なものにな
らざるを得ない。更に、CPPはペプチドであるため、
胃液や腸液(特に十二指腸液)に含まれる蛋白分解酵素
により消化されると効果を失う欠点があった。
[0005] CPP is a peptide of about 20 amino acids that contains four phosphoserines (each having one phosphate radical) on the terminal side of a protein (β-casein) that accounts for about 22% of the total casein protein ( Presented at the Japanese Society of Food and Nutrition in 1985; Identification of casein phosphopeptide in rat small intestine and investigation of Ca, Fe solubilization ability, University of Tokyo Agricultural Chemicals, Ryuichiro Sato, Tadashi Noguchi, Hiroshi Naito). On the other hand, the molecular weight of this β-casein is 20,000 to 30,000, and CPP obtained from casein
is only about 1/50th. Therefore, CP than casein
When producing P, disposal of the remaining components becomes an issue. Casein itself is a protein isolated from animal milk. These factors inevitably make CPP quite expensive. Furthermore, since CPP is a peptide,
It has the disadvantage that it loses its effectiveness when digested by proteolytic enzymes contained in gastric juice and intestinal juice (particularly duodenal juice).

【0006】そこで、本発明者はCPPに代わる安価で
且つ体内の蛋白分解酵素により消化されずに、しかも効
率良く生産されるカルシュウム吸収促進剤を開発するた
め鋭意研究した。先ず、カルシュウム吸収促進剤の持つ
べき機能として、■  摂取されたカルシュウムが胃の
酸で可溶化された後、腸に送られ、pHの変化(中性域
)により不溶化させられるのを防ぐことにより、吸収可
能なカルシュウム濃度を高めることができる。そこで、
カルシュウム吸収剤はカルシュウムイオンと結合するラ
ジカルを持つこと。■  たとえばEDTAは鉄Feと
の結合が強固であるため、吸収低下を招くことが確認さ
れている(前出、日本食糧栄養学会昭和60年度発表;
ラット小腸内カゼインホスホペプチドの同定とCa,F
e 可溶化能の検討、東大農化、佐藤隆一郎,野口忠,
内藤博)。同様に、カルシュウム吸収促進剤はカルシュ
ウムイオンとの結合が強すぎると、可溶化されたカルシ
ュウムが吸収されなくなる恐れがある。そこで、カルシ
ュウムと結合するラジカルは、適度な親和力であること
。が必要である。
[0006] Therefore, the present inventor conducted extensive research in order to develop a calcium absorption enhancer that is inexpensive to replace CPP, is not digested by proteolytic enzymes in the body, and is efficiently produced. First, the functions that a calcium absorption enhancer should have are: - After ingested calcium is solubilized by stomach acid, it is sent to the intestines, and by preventing it from being insolubilized due to changes in pH (neutral range). , can increase the absorbable calcium concentration. Therefore,
Calcium absorbents must have radicals that combine with calcium ions. ■ For example, it has been confirmed that EDTA has a strong bond with iron, which leads to decreased absorption (see above, published by the Japanese Society of Food and Nutrition in 1985;
Identification of casein phosphopeptides in rat small intestine and Ca, F
e Examination of solubilization ability, Department of Agriculture, University of Tokyo, Ryuichiro Sato, Tadashi Noguchi,
Hiroshi Naito). Similarly, if the calcium absorption enhancer has too strong a bond with calcium ions, there is a risk that solubilized calcium will not be absorbed. Therefore, the radical that binds to calcium must have a moderate affinity. is necessary.

【0007】本発明者はミネラル吸収阻害物質であるフ
ィチン酸はカルシュウムに対する挙動が上述の機能と極
めて類似し、唯一カルシュウム塩が不溶性である点だけ
が異なることに着目し、これを改良すれば一転してミネ
ラル吸収促進物質になることを予想し、研究を進めた。
The present inventor focused on the fact that the behavior of phytic acid, which is a mineral absorption inhibitor, with respect to calcium is extremely similar to the above-mentioned function, and the only difference is that calcium salt is insoluble. We anticipated that it would become a substance that promotes mineral absorption, and conducted research on it.

【0008】[0008]

【発明が解決しようとする課題】フィチン酸は広く穀類
中に存在し、Zn, Mg, Ca, Fe等と結合し
、ミネラルの吸収阻害を起こす(化学同人発行;生化学
辞典)ことが昔から確認されている。たとえば、亜鉛Z
nの吸収率も食事内容次第で大きく変動し、特に、食品
の中に含まれているフィチン酸やそして若干は食物繊維
によって、亜鉛の吸収がさまたげられるとの実例の報告
がなされている。 発展途上国、特にイラン等で1960年に、初めて「ヒ
トのZn欠乏症」が突き止められた。すなわち「醗酵パ
ン」を常食している都市部ではトラブルは無かったが、
「未醗酵パン」を常食している田舎部では顕著な成長阻
害、性器の未発達が確認された。本例において、RAD
 の3〜5倍(30〜50mg/日)のZnの病理的投
与量で治療し得たと報告しており、このトラブルは激し
いZn欠乏症が原因と考えられている(A.S.Pra
sad 「Deficiency of Znin M
an and its Toxicity」、Trac
e Elements in Human Healt
h and Dise−ase(Vol.1).,Ac
ademic Press.,1976,ISBN 0
−12−564201−6)。
[Problem to be solved by the invention] Phytic acid is widely present in grains, and has long been known to bind with Zn, Mg, Ca, Fe, etc. and inhibit the absorption of minerals (published by Kagaku Doujin; Biochemistry Dictionary). Confirmed. For example, zinc Z
The absorption rate of n also varies greatly depending on the content of the meal, and there have been actual reports that the absorption of zinc is hindered by phytic acid and, to some extent, dietary fiber contained in foods. In 1960, ``human Zn deficiency'' was first identified in developing countries, particularly Iran. In other words, there were no problems in urban areas where "fermented bread" was eaten regularly,
In rural areas where people regularly eat ``unfermented bread'', significant growth inhibition and underdevelopment of genital organs have been confirmed. In this example, RAD
It has been reported that treatment was possible with a pathological dose of Zn that was 3 to 5 times the normal dose (30 to 50 mg/day), and this problem is thought to be caused by severe Zn deficiency (A.S. Pra.
sad “Deficiency of Znin M
and its Toxicity”, Trac
eElements in Human Healt
h and Dise-ase (Vol.1). , Ac
academic Press. , 1976, ISBN 0
-12-564201-6).

【0009】また、一般に穀物中に含まれるリンPのう
ちかなり多くの成分はフィチン酸として存在していて、
消化系内で「フィチン酸カルシュウム」を生成して不溶
物となり、不消化のままで糞便排泄されるので、Pだけ
でなくCaの吸収も妨げられることになる。特に、全穀
粒ではフィチン酸態のP塩が多いが、人類の長い歴史の
知恵でパンの酵母醗酵が行われて食されていて、この酵
母中のフィターゼ(Phytase)がこのフィチン酸
を分解するのでCaの吸収阻害の心配はなかった。しか
し、未醗酵の全穀粒パンを食べていた中近東やアジア地
域では、Caの吸収が阻害されて、骨軟化症のトラブル
を起こしていたのである( C.M.Berlyne 
et al「Osteomatacia due to
 Ca Deprivation caused by
 high phyticacid Concentr
ation ofunleavened bread」
,Am.J.Clin.Nutri.26,1973)
[0009] In general, a considerable amount of the phosphorus P contained in grains exists as phytic acid.
Calcium phytate is produced in the digestive system and becomes an insoluble substance, which is excreted in the feces undigested, which impedes the absorption of not only P but also Ca. In particular, whole grains contain a large amount of P salt in the form of phytic acid, but bread is eaten by yeast fermentation based on the wisdom of humankind's long history, and phytase in this yeast breaks down this phytic acid. Therefore, there was no concern about inhibition of Ca absorption. However, in the Middle East and Asia, where people ate unfermented whole-grain bread, Ca absorption was inhibited, causing osteomalacia (CM Berlyne).
et al “Osteomatacia due to
Ca Deprivation caused by
High phyticacid Concentr
ation ofunleaved bread”
, Am. J. Clin. Nutri. 26, 1973)
.

【0010】以上の実例の報告より、フィチン酸のミネ
ラル吸収阻害はフィチン酸とミネラルとの結合体が不溶
性であることに原因があると考えられる。また、このミ
ネラル吸収阻害の改善はパンの醗酵時のフィターゼによ
るフィチン酸の分解反応で行われていると考えられる。 しかしながら、どの程度フィチン酸が分解されれば良い
かは不明である。そこで、本発明者はその点の解明を行
いカルシュウムを始めとするミネラル吸収促進剤を得る
とともに、その主成分を成すフィチン酸部分分解物とそ
の金属塩の製造方法を発明するに至った。
[0010] From the reports of the above examples, it is thought that the inhibition of mineral absorption by phytic acid is caused by the insolubility of the conjugate of phytic acid and minerals. Furthermore, this improvement in mineral absorption inhibition is thought to be achieved through the decomposition reaction of phytic acid by phytase during bread fermentation. However, it is unclear to what extent phytic acid should be decomposed. Therefore, the present inventor has clarified this point and obtained a mineral absorption enhancer including calcium, and has also invented a method for producing a partial decomposition product of phytic acid, which is the main component thereof, and a metal salt thereof.

【0011】[0011]

【課題を解決するための手段】本発明に係るミネラル吸
収促進剤の要旨とするところは、フィチン酸又はその塩
類が有するリン酸ラジカルの数が少なくとも5以下、好
ましくは2以上5以下であるフィチン酸部分分解物又は
該金属塩を主成分とすることにある。
[Means for Solving the Problems] The gist of the mineral absorption enhancer according to the present invention is that phytic acid or a salt thereof has at least 5 or less phosphoric acid radicals, preferably 2 or more and 5 or less. The main component is an acid partial decomposition product or the metal salt.

【0012】また、本発明に係るフィチン酸部分分解物
の製造方法の要旨とするところは、フィチン酸又はその
塩類にフィターゼを作用させて、リン酸ラジカルが全て
遊離しない範囲内で加水分解を起させたことにある。
[0012] The gist of the method for producing a partially decomposed product of phytic acid according to the present invention is that phytase is allowed to act on phytic acid or its salts to cause hydrolysis within a range in which all phosphoric acid radicals are not liberated. It's because I let it happen.

【0013】更に、本発明に係る他のフィチン酸部分分
解物の製造方法の要旨とするところは、フィチン酸又は
その塩類を酸性加熱下で、更に必要に応じて加圧して、
リン酸ラジカルが全て遊離しない範囲内で加水分解を起
させたことにある。
Furthermore, the gist of another method for producing a partially decomposed phytic acid product according to the present invention is that phytic acid or its salts are heated under acidic conditions and optionally pressurized.
This is due to the fact that hydrolysis occurred within a range in which all phosphoric acid radicals were not liberated.

【0014】次に、本発明に係るフィチン酸部分分解物
の金属塩の製造方法の要旨とするところは、前記製造方
法により得られたフィチン酸部分分解物に金属塩水溶液
を添加して不溶物を除去し、一方、生成されたフィチン
酸部分分解物の金属塩にアルコールを添加して該金属塩
を沈澱物として取り出し、該沈澱物を乾燥させて粉末に
したことにある。
Next, the gist of the method for producing a metal salt of a partially decomposed phytic acid product according to the present invention is to add an aqueous solution of a metal salt to the partially decomposed phytic acid product obtained by the above-mentioned production method to form an insoluble material. was removed, alcohol was added to the metal salt of the partially decomposed phytic acid product produced, the metal salt was taken out as a precipitate, and the precipitate was dried to form a powder.

【0015】[0015]

【作用】本発明に係るミネラル吸収促進剤は、フィチン
酸又はその塩類の分子内に6個あるリン酸ラジカルを少
なくとも1個以上取り除いた5個以下のリン酸ラジカル
を持つフィチン酸部分分解物はカルシュウムの吸収を阻
害しないだけでなく、その吸収を促進することが判明し
、フィチン酸部分分解物又はその金属塩を主成分とする
ミネラル吸収促進剤が得られたのである。得られたミネ
ラル吸収促進剤はカルシュウムを豊富に含む食品、ある
いはカルシュウムを添加した食品に0.05%以上、望
ましくは0.2 %以上量を添加すればカルシュウムの
吸収促進の目的が達成される。
[Action] The mineral absorption enhancer according to the present invention is a partially decomposed product of phytic acid having 5 or less phosphoric acid radicals, which is obtained by removing at least one of the 6 phosphoric acid radicals in the molecule of phytic acid or its salts. It was found that this method not only does not inhibit the absorption of calcium, but also promotes its absorption, and a mineral absorption enhancer whose main component is a partially decomposed product of phytic acid or a metal salt thereof has been obtained. The purpose of promoting calcium absorption can be achieved by adding the obtained mineral absorption enhancer to foods rich in calcium or foods to which calcium has been added in an amount of 0.05% or more, preferably 0.2% or more. .

【0016】次に、ミネラル吸収促進剤の主成分を成す
フィチン酸部分分解物はミネラル吸収阻害物質であるフ
ィチン酸あるいはその塩類の水溶液にパン酵母や小麦フ
ィターゼを用いてそれぞれ適切な反応条件で接触させて
分解反応させ、リン酸ラジカルが遊離させられる。遊離
してくる無機リンを定量し、適度に分解反応が進んだと
ころで酵素を加熱失活させたり、あるいはアルカリを添
加してpHの変化によって酵素を失活させた後、不溶物
を除去して、フィチン酸部分分解物溶液を得ることがで
きる。
Next, the partially decomposed product of phytic acid, which is the main component of the mineral absorption enhancer, is brought into contact with an aqueous solution of phytic acid or its salts, which is a mineral absorption inhibitor, using baker's yeast or wheat phytase under appropriate reaction conditions. This causes a decomposition reaction, and phosphoric acid radicals are liberated. After quantifying the liberated inorganic phosphorus and deactivating the enzyme by heating after the decomposition reaction has progressed appropriately, or by adding alkali and deactivating the enzyme by changing the pH, insoluble matter is removed. , a phytic acid partial decomposition product solution can be obtained.

【0017】また、フィチン酸部分分解物はミネラル吸
収阻害物質であるフィチン酸あるいはその塩類の水溶液
を酸性加熱下で、更に必要に応じて加圧して水溶液が沸
騰しないようにして化学反応させて、リン酸ラジカルが
遊離させられる。この遊離してくる無機リンを定量し、
適度に分解反応が進んだところでアルカリ溶液を入れて
反応を停止させ、次いで不溶物を除去してフィチン酸部
分分解物溶液が得られる。
[0017] Phytic acid partially decomposed products are prepared by chemically reacting an aqueous solution of phytic acid or its salts, which is a mineral absorption inhibitor, under acidic heating and, if necessary, applying pressure to prevent the aqueous solution from boiling. Phosphate radicals are liberated. Quantitate this liberated inorganic phosphorus,
When the decomposition reaction has progressed to a suitable level, an alkaline solution is added to stop the reaction, and then insoluble matter is removed to obtain a phytic acid partially decomposed product solution.

【0018】更に、得られたフィチン酸部分分解物溶液
にカルシュウム水溶液、あるいは他の金属塩が希望され
るなら該当する金属塩水溶液を添加し、不溶物を除去し
て塩として得ることができる。このとき未反応のフィチ
ン酸は除去される。このフィチン酸部分分解物の金属塩
はアルコールの添加により沈殿物として得られ、取り出
して乾燥することにより粉末として得ることができる。
Furthermore, if an aqueous calcium solution or another metal salt is desired, an aqueous solution of a corresponding metal salt can be added to the obtained phytic acid partially decomposed product solution to remove insoluble matter to obtain the salt. At this time, unreacted phytic acid is removed. The metal salt of this partially decomposed phytic acid product is obtained as a precipitate by adding alcohol, and can be obtained as a powder by taking it out and drying it.

【0019】[0019]

【実施例】次に、本発明の実施例を詳しく説明する。本
発明のミネラル吸収促進剤の主成分であるフィチン酸部
分分解物の原料となるフィチン酸は穀物の精製過程で取
り除かれる食用に適さないたとえば糠などに多量に存在
しており、公知の手法で抽出して取り出され用いられる
。また、フィチン酸の塩類はナトリウム塩、カルシュウ
ム塩、マグネシウム塩などが用いられる。
EXAMPLES Next, examples of the present invention will be described in detail. Phytic acid, which is the raw material for the partially decomposed phytic acid product that is the main component of the mineral absorption enhancer of the present invention, exists in large amounts in inedible grains, such as rice bran, which are removed during the refining process of grains. It is extracted and used. Further, as the salts of phytic acid, sodium salt, calcium salt, magnesium salt, etc. are used.

【0020】このフィチン酸あるいはその塩類の水溶液
にフィターゼが加えられて加水分解され、リン酸ラジカ
ルが遊離させられる。フィターゼは市販の小麦フィター
ゼの他、パン酵母に含まれていることからパン酵母その
ものが用いられる。フィターゼによるフィチン酸又はそ
の塩類の加水分解は分子内に6個あるリン酸ラジカルが
全て遊離してイノシトール(イノシット)になる前の、
少なくとも1個のリン酸ラジカルが遊離した1以上5以
下のリン酸ラジカルを有するフィチン酸部分分解物の状
態で分解が停止させられる。特に、カルシュウムなどの
ミネラルと結合するリン酸ラジカルが多数存在する2以
上5以下のリン酸ラジカルを有するフィチン酸部分分解
物が好ましい。フィターゼによる加水分解の停止は酵素
失活によって行われ、酵素失活は加熱、あるいはアルカ
リなどによるpHの変化などにより行われる。
[0020] Phytase is added to this aqueous solution of phytic acid or its salts to cause hydrolysis, thereby liberating phosphoric acid radicals. In addition to commercially available wheat phytase, phytase is contained in baker's yeast, so baker's yeast itself is used. Hydrolysis of phytic acid or its salts by phytase involves the hydrolysis of phytic acid or its salts before all six phosphate radicals in the molecule are liberated and become inositol.
Decomposition is stopped in the state of a phytic acid partial decomposition product having 1 or more and 5 or less phosphoric acid radicals in which at least one phosphoric acid radical is liberated. Particularly preferred is a partially decomposed product of phytic acid having 2 or more and 5 or less phosphoric acid radicals, in which a large number of phosphoric acid radicals bond with minerals such as calcium. Hydrolysis by phytase is stopped by deactivating the enzyme, and deactivation of the enzyme is performed by heating or by changing the pH using an alkali or the like.

【0021】一方、このフィチン酸又はその塩類の加水
分解はフィターゼに代えて、無機酸を加えることによっ
ても行われる。たとえば塩酸などの無機酸を加えて、反
応を促進させるために加熱下で加水分解させられる。こ
こで、加熱されたフィチン酸又はその塩類の水溶液を沸
騰させないように熱管理し、工業的に量産するために加
圧下でこの反応を行うようにしても良い。フィチン酸又
はその塩類を加水分解させる程度は上述したように、リ
ン酸ラジカルが全て遊離してイノシトールになる前のフ
ィチン酸部分分解物の状態とされる。かかる反応の停止
はフィチン酸がアルカリに対して安定であることから、
濃アンモニア水などのアルカリ溶液を加えることによっ
てなされる。
On the other hand, the hydrolysis of phytic acid or its salts can also be carried out by adding an inorganic acid instead of phytase. For example, an inorganic acid such as hydrochloric acid is added and hydrolyzed under heat to accelerate the reaction. Here, the heat may be controlled so as not to boil the heated aqueous solution of phytic acid or its salts, and this reaction may be carried out under pressure for industrial mass production. As mentioned above, the extent to which phytic acid or its salts are hydrolyzed is determined to be in the state of a partially decomposed product of phytic acid before all phosphoric acid radicals are liberated and become inositol. This reaction is stopped because phytic acid is stable against alkalis.
This is done by adding an alkaline solution such as concentrated aqueous ammonia.

【0022】次に、フィチン酸又はその塩類を部分分解
させたフィチン酸部分分解物の溶液から遠心分離法や濾
過法により不溶物が取り除かれ、精製されたフィチン酸
部分分解物の溶液が製造される。
Next, insoluble matter is removed from the solution of the partially decomposed phytic acid obtained by partially decomposing phytic acid or its salts by centrifugation or filtration, and a purified solution of the partially decomposed phytic acid is produced. Ru.

【0023】このような溶液状のフィチン酸部分分解物
に更にカルシュウム水溶液や、あるいはカルシュウム以
外のミネラルが望まれる場合はその金属塩の水溶液を添
加して、生成した不溶物が遠心分離や濾過などによって
除去される。生成した不溶物は主として未反応のフィチ
ン酸のカルシュウム塩又は金属塩である。不溶物が除去
され精製された溶液状のフィチン酸部分分解物の金属塩
にエタノールなどのアルコールを添加し、その金属塩が
沈澱させられる。沈澱物として得られたフィチン酸部分
分解物の金属塩は乾燥させられ、粉末状の金属塩が得ら
れる。 実施例  1 7グラムのフィチン酸ナトリウム(シグマケミカル社製
)を3000mlの酢酸ナトリウム緩衝液(pH4.6
)に溶解した。この溶解液にウエットケーキ状の業務用
パン酵母 (水分72%、窒素含有量2%、リン含有量
 0.4%)250グラムを攪拌しながら加え、45℃
にて分解反応を行った。フィチン酸ナトリウムがパン酵
母によって分解され遊離させられてくる無機リンの量を
時間の経過と共に測定した。その測定結果を遊離してく
る無機リンの量を全リン量に対する百分率で表したリン
酸遊離率を縦軸に、反応時間を横軸にして図2に示した
。同図をフィチン酸ナトリウムのパン酵母による分解反
応の程度の目安とした。
[0023] An aqueous calcium solution or, if a mineral other than calcium is desired, an aqueous solution of a metal salt thereof is further added to the partially decomposed product of phytic acid in the form of a solution, and the resulting insoluble matter is removed by centrifugation, filtration, etc. removed by The produced insoluble matter is mainly unreacted calcium salt or metal salt of phytic acid. An alcohol such as ethanol is added to the metal salt of a partially decomposed phytic acid solution in which insoluble matter has been removed and purified, and the metal salt is precipitated. The metal salt of the partially decomposed phytic acid product obtained as a precipitate is dried to obtain a powdery metal salt. Example 1 7 grams of sodium phytate (manufactured by Sigma Chemical Co.) was added to 3000 ml of sodium acetate buffer (pH 4.6).
) dissolved in 250 grams of commercial baker's yeast in the form of a wet cake (moisture 72%, nitrogen content 2%, phosphorus content 0.4%) was added to this solution while stirring, and the mixture was heated to 45°C.
A decomposition reaction was carried out. The amount of inorganic phosphorus liberated by the decomposition of sodium phytate by baker's yeast was measured over time. The measurement results are shown in FIG. 2, where the phosphoric acid release rate, in which the amount of inorganic phosphorus released is expressed as a percentage of the total phosphorus amount, is plotted on the vertical axis, and the reaction time is plotted on the horizontal axis. The figure was used as a guide for the degree of decomposition reaction of sodium phytate by baker's yeast.

【0024】実施例  2 先ず実施例1と同様の条件でフィチン酸ナトリウムを酢
酸ナトリウム緩衝液に溶解し、その溶解液にパン酵母を
攪拌させて分解反応を行った。図2に示すリン酸遊離率
と反応時間との関係に基づいて、リン酸遊離率が約25
%となる反応時間約2時間の反応液に、濃アンモニア水
を反応液のpHが12になるまで添加し、パン酵母によ
るフィチン酸ナトリウムの分解反応を停止させた。次に
、その反応液を遠心分離して上澄液を集めた。得られた
上澄液をイオン交換樹脂(ダウエックス1、クロライド
形)に通じて生成したフィチン酸部分分解物(PDP)
を吸着させた後、1規定塩酸にてそのフィチン酸部分分
解物(PDP)をイオン交換樹脂から溶出させた。この
ようにして得たフィチン酸部分分解物(PDP)溶液を
無機リン25%を離脱分解させたリン酸遊離率25%の
分解物としてPDP−25とした。
Example 2 First, sodium phytate was dissolved in a sodium acetate buffer under the same conditions as in Example 1, and baker's yeast was stirred in the solution to carry out a decomposition reaction. Based on the relationship between the phosphoric acid release rate and the reaction time shown in Figure 2, the phosphoric acid release rate is approximately 25%.
%, and the reaction time was about 2 hours.Concentrated ammonia water was added to the reaction solution until the pH of the reaction solution reached 12 to stop the decomposition reaction of sodium phytate by baker's yeast. Next, the reaction solution was centrifuged to collect the supernatant. Phytic acid partial decomposition product (PDP) was produced by passing the obtained supernatant through an ion exchange resin (DOWEX 1, chloride type).
After adsorption, the phytic acid partial decomposition product (PDP) was eluted from the ion exchange resin with 1N hydrochloric acid. The thus obtained phytic acid partial decomposition product (PDP) solution was designated as PDP-25 as a decomposition product with a phosphoric acid release rate of 25% by decomposing and removing 25% of inorganic phosphorus.

【0025】同様にして、リン酸遊離率が約30%とな
る3時間反応、同じく約40%となる6時間反応、及び
同じく約50%となる12時間反応を行い、それぞれP
DP−30, PDP−40およびPDP−50の水溶
液を得た。得られたそれぞれのフィチン酸部分分解物溶
液に含まれるフィチン酸リン酸エステル類の高速液体ク
ロマトグラフィーHPLPによるパターンは図3、図4
、図5及び図6に示す通りであった。ここで、高速液体
クロマトグラフィーはWhatman Partisi
l 10 SAXcolumnを用い、溶離法は95%
 H2 O /5%MeOHで10分間溶離した後、続
いて95%0.7N HCl/5%MeOHで30分間
傾斜溶離した。図中、■はイノシトール、■はイノシト
ールモノホスフェイト、■はイノシトールジホスフェイ
ト、■はイノシトールトリホスフェイト、■はイノシト
ールテトラホスフェイト、■はイノシトールペンタホス
フェイト、■はイノシトールヘキサホスフェイトを示す
。これらの図より、PDP−25は分解反応が初期の状
態にあり、PDP−50はかなり分解反応が進んでいる
ことが分かる。
Similarly, a 3-hour reaction with a phosphoric acid release rate of about 30%, a 6-hour reaction with a phosphoric acid release rate of about 40%, and a 12-hour reaction with a phosphoric acid release rate of about 50% were carried out in the same manner.
Aqueous solutions of DP-30, PDP-40 and PDP-50 were obtained. The patterns of phytic acid phosphate esters contained in each obtained phytic acid partial decomposition product solution by high performance liquid chromatography (HPLP) are shown in Figures 3 and 4.
, as shown in FIGS. 5 and 6. Here, high performance liquid chromatography is performed using Whatman Partisi
The elution method was 95% using l 10 SAX column.
Elution with H2O/5% MeOH for 10 min followed by gradient elution with 95% 0.7N HCl/5% MeOH for 30 min. In the figure, ■ represents inositol, ■ represents inositol monophosphate, ■ represents inositol diphosphate, ■ represents inositol triphosphate, ■ represents inositol tetraphosphate, ■ represents inositol pentaphosphate, and ■ represents inositol hexaphosphate. From these figures, it can be seen that the decomposition reaction of PDP-25 is in the initial state, and the decomposition reaction of PDP-50 has progressed considerably.

【0026】実施例  3 実施例2で得られた4種類のPDP溶液(PDP−25
、PDP−30, PDP−40、PDP−50)50
0mlに、それぞれ水酸化カルシュウム水溶液を加えて
約pH7に中和した。生じた沈澱物を遠心分離して除い
た。 沈澱物は主に未反応のフィチン酸のカルシュウム塩であ
った。得られた上澄液に500mlのエタノールを添加
することによりフィチン酸部分分解物PDPをカルシュ
ウム塩として沈澱させた。この沈澱物を遠心分離し、再
度溶解、エタノール沈澱を繰り返して精製した後、真空
乾燥し、それぞれPDP−25Ca塩、PDP−30C
a塩、PDP−40Ca塩、PDP−50Ca塩の粉末
を得ることが出来た。
Example 3 Four types of PDP solutions obtained in Example 2 (PDP-25
, PDP-30, PDP-40, PDP-50) 50
An aqueous calcium hydroxide solution was added to 0 ml of each to neutralize the pH to about 7. The resulting precipitate was removed by centrifugation. The precipitate was mainly unreacted calcium salt of phytic acid. By adding 500 ml of ethanol to the obtained supernatant, phytic acid partial decomposition product PDP was precipitated as a calcium salt. This precipitate was centrifuged, redissolved, and purified by repeating ethanol precipitation, and then vacuum dried to obtain PDP-25Ca salt and PDP-30C, respectively.
It was possible to obtain powders of a salt, PDP-40Ca salt, and PDP-50Ca salt.

【0027】実施例  4 胃液と近い濃度の塩酸溶液(pH1.5) にリン酸カ
ルシュウム粉末をカルシュウム濃度として0.1M懸濁
し、更に実施例3で製造したPDP−25Ca塩粉末を
0.01%添加し、体温に近い温度37℃で1時間攪拌
して可溶化した。その後、液のpHをカセイソーダ液で
腸の条件に近い6.8 に調節し、可溶化しているカル
シュウムが時間の経過とともに不溶化していく様子を調
べた。カルシュウム濃度の測定は一定時間経過後、液の
一部を採取し、遠心分離して上澄液中のカルシュウム濃
度を原子吸光により測定した。測定結果を図1に示す。
Example 4 Calcium phosphate powder was suspended in a hydrochloric acid solution (pH 1.5) with a concentration close to that of gastric juice at a calcium concentration of 0.1M, and the PDP-25Ca salt powder produced in Example 3 was further suspended at 0.01%. and stirred for 1 hour at 37° C., which is close to body temperature, to solubilize. Thereafter, the pH of the solution was adjusted to 6.8 with caustic soda solution, which is close to the intestinal conditions, and the solubilized calcium was examined to see how it became insolubilized over time. To measure the calcium concentration, a portion of the liquid was collected after a certain period of time, centrifuged, and the calcium concentration in the supernatant was measured by atomic absorption. The measurement results are shown in Figure 1.

【0028】同様の条件でPDP−30Ca塩、PDP
−40Ca塩、PDP−50Ca塩の粉末についてもそ
れぞれ実験を行い、可溶化させたカルシュウムが時間の
経過とともに不溶化していく様子を調べた。測定結果を
図1に示す。
Under similar conditions, PDP-30Ca salt, PDP
Experiments were also conducted using powders of -40Ca salt and PDP-50Ca salt, and the manner in which solubilized calcium became insolubilized over time was investigated. The measurement results are shown in Figure 1.

【0029】比較例  1 実施例4と同様に、胃液と近い濃度の塩酸溶液(pH1
.5) にリン酸カルシュウム粉末をカルシュウム濃度
として0.1M懸濁し、本比較例1ではPDP塩粉末を
添加せずに、体温に近い温度37℃で1時間攪拌して可
溶化した。その後、液のpHをカセイソーダ液で腸の条
件に近い6.8 に調節し、可溶化しているカルシュウ
ムが時間の経過とともに不溶化していく様子を調べた。 カルシュウム濃度の測定は一定時間経過後、液の一部を
採取し、遠心分離して上澄液中のカルシュウム濃度を原
子吸光により測定した。測定結果を図1に示す。
Comparative Example 1 Similar to Example 4, a hydrochloric acid solution (pH 1
.. 5) Calcium phosphate powder was suspended at a calcium concentration of 0.1 M, and in Comparative Example 1, without adding PDP salt powder, the suspension was stirred for 1 hour at a temperature of 37° C. close to body temperature to solubilize. Thereafter, the pH of the solution was adjusted to 6.8 with caustic soda solution, which is close to the intestinal conditions, and the solubilized calcium was examined to see how it became insolubilized over time. To measure the calcium concentration, a portion of the liquid was collected after a certain period of time, centrifuged, and the calcium concentration in the supernatant was measured by atomic absorption. The measurement results are shown in Figure 1.

【0030】図1に示すように、PDP塩粉末(PDP
−25Ca塩、PDP−30Ca塩、PDP−40Ca
塩、PDP−50Ca塩)を添加して可溶化したカルシ
ュウムは時間の経過とともに若干不溶化させられるのが
認められた。一方、PDP塩粉末を添加せずに可溶化し
たカルシュウムは時間の経過とともに大幅に不溶化させ
られ、カルシュウム濃度が低下するのが認められた。以
上より、4種類のPDP塩粉末はいずれも著しいカルシ
ウム不溶化防止効果が認められた。
As shown in FIG. 1, PDP salt powder (PDP
-25Ca salt, PDP-30Ca salt, PDP-40Ca
It was observed that the calcium solubilized by adding salt, PDP-50Ca salt) became slightly insolubilized over time. On the other hand, calcium solubilized without adding PDP salt powder was significantly insolubilized with the passage of time, and it was observed that the calcium concentration decreased. From the above, all four types of PDP salt powder were recognized to have a remarkable effect of preventing calcium insolubilization.

【0031】実施例  5 体重約70グラムのSD系雄ラット2匹について16時
間絶食させた後、麻酔下で開腹し、盲腸より上部10セ
ンチメートルの位置、及びさらに10センチメートル程
度上部の回腸部を絹糸を用いて結紮し、内容物の上部よ
りの流入及び下部への流出等の移動がない状態にした。 結紮した腸管内に生理食塩水1ml当たりPDP−30
Ca塩4mgを溶解させた溶解液を0.25ml注射し
、更に塩化カルシュウム溶液(カルシュウムとして40
mM)を0.25ml注射した。
Example 5 Two SD male rats weighing approximately 70 grams were fasted for 16 hours, then their abdomens were opened under anesthesia, and the ileum was excised at a position 10 cm above the cecum and about 10 cm further above. was ligated with silk thread to prevent the contents from flowing in from the top or out from the bottom. PDP-30 per ml of saline into the ligated intestinal tract.
Inject 0.25 ml of a solution containing 4 mg of Ca salt, and then inject 0.25 ml of a solution containing 4 mg of Ca salt.
0.25 ml of mM) was injected.

【0032】実験に用いた2匹のラットのうち1匹は直
ちに 0.1N塩酸水溶液にて腸管内容物を回収し、遠
心分離した後、その上澄液のカルシュウム量を測定し、
吸収ゼロタイムとして数値を求めた。ラットのうち他の
1匹は先の塩化カルシュウム溶液の注射後、時間を置か
ずに直ちに40mMのpH8のリン酸緩衝液を0.25
ml注射し、一旦腸管を腹中に戻して、生理的条件がで
きるだけ自然に保たれるようにした。2時間後再び開腹
し、前述の吸収ゼロタイムの時と同様にしてカルシュウ
ム量を測定した。その結果を表1に示す。なお、カルシ
ュウム量は全カルシュウム量である。同図に示すように
、2時間後における吸収量は0.21mgであり、また
ゼロタイム時のカルシュウム量に対する吸収量の百分率
は40%であった
The intestinal contents of one of the two rats used in the experiment were immediately collected with a 0.1N aqueous hydrochloric acid solution, centrifuged, and the amount of calcium in the supernatant was measured.
The value was determined as absorption zero time. The other rat received 0.25% of 40mM pH 8 phosphate buffer immediately after the previous injection of calcium chloride solution.
ml injection, and the intestinal tract was once returned to the abdomen to maintain physiological conditions as natural as possible. Two hours later, the abdomen was opened again, and the amount of calcium was measured in the same manner as at the zero absorption time described above. The results are shown in Table 1. Note that the amount of calcium is the total amount of calcium. As shown in the figure, the absorbed amount after 2 hours was 0.21 mg, and the percentage of absorbed amount to the amount of calcium at zero time was 40%.

【表1】[Table 1]

【0033】比較例  2 実施例5と同様に、ほぼ同じ体重のラット2匹を用い、
結紮した腸管にPDPを含まない生理食塩水を0.25
ml注射し、更に同様に塩化カルシュウム溶液を同量注
射した。そして、ラット2匹のうち1匹はゼロタイム時
に、他の1匹は2時間後に同様の条件でカルシュウム量
を測定した。その結果を表1に示す。同表から分かるよ
うに、比較例2の吸収率は14%であり、実施例5の約
3分の1であった。
Comparative Example 2 In the same manner as in Example 5, two rats of approximately the same weight were used,
Inject 0.25% of physiological saline without PDP into the ligated intestinal tract.
ml was injected, and the same amount of calcium chloride solution was further injected in the same manner. Then, the amount of calcium was measured in one of the two rats at zero time and in the other 2 hours later under the same conditions. The results are shown in Table 1. As can be seen from the table, the absorption rate of Comparative Example 2 was 14%, which was about one third of that of Example 5.

【0034】[0034]

【発明の効果】本発明に係るミネラル吸収促進剤はフィ
チン酸部分分解物又はその金属塩を主成分とし、かかる
ミネラル吸収促進剤をカルシュウムを初めとするミネラ
ルとともに摂取されると、摂取されたミネラルが胃液の
酸で可溶化された後、小腸に送られ中性域へpHの変化
により不溶化するのが防止され、吸収可能なミネラル濃
度を高めることができる。また、フィチン酸部分分解物
又はその金属塩と結合させられたミネラルはその結合が
強すぎることがないため、可溶化されたミネラルは充分
吸収される。更に、これらフィチン酸部分分解物やその
金属塩は胃液や腸液に含まれる蛋白分解酵素などによっ
て消化されることはなく、ミネラル吸収促進剤の効果を
失うことはない。しかも、フィチン酸部分分解物やその
金属塩を製造する原料であるフィチン酸やその塩類は食
用に適さない糠などに多量に含まれていて、安価である
Effects of the Invention The mineral absorption enhancer according to the present invention has a partial decomposition product of phytic acid or its metal salt as a main component, and when such a mineral absorption enhancer is ingested together with minerals such as calcium, the ingested minerals are reduced. After being solubilized by the acid in the gastric fluid, it is sent to the small intestine and is prevented from becoming insolubilized by changes in pH to a neutral range, increasing the concentration of absorbable minerals. Moreover, since the minerals bound to the phytic acid partial decomposition product or its metal salt are not too strongly bound, the solubilized minerals are sufficiently absorbed. Furthermore, these phytic acid partial decomposition products and their metal salts are not digested by proteolytic enzymes contained in gastric juice or intestinal juice, and do not lose their effectiveness as mineral absorption promoters. Moreover, phytic acid and its salts, which are raw materials for producing phytic acid partial decomposition products and its metal salts, are contained in large amounts in inedible rice bran and the like, and are therefore inexpensive.

【0035】また、本発明に係るミネラル吸収促進剤の
主成分であるフィチン酸部分分解物又はその金属塩はパ
ン酵母などに含まれているフィターゼを用いたり、ある
いは無機酸を添加することによって、加水分解反応によ
りリン酸ラジカルを遊離させるとともに、リン酸ラジカ
ルが全て遊離しない範囲内で停止させることによって容
易に製造することができる。更に、粉末化することによ
って取扱いや保管が簡単になるなどの効果がある。
Furthermore, the phytic acid partial decomposition product or its metal salt, which is the main component of the mineral absorption enhancer according to the present invention, can be prepared by using phytase contained in baker's yeast or by adding an inorganic acid. It can be easily produced by liberating phosphoric acid radicals through a hydrolysis reaction and stopping the reaction within a range in which all phosphoric acid radicals are not liberated. Furthermore, by pulverizing it, it becomes easier to handle and store.

【図面の簡単な説明】[Brief explanation of the drawing]

【図1】本発明に係るミネラル吸収促進剤を添加した場
合と添加していない場合におけるカルシュウム濃度の変
化を示す図である。
FIG. 1 is a diagram showing changes in calcium concentration when a mineral absorption enhancer according to the present invention is added and when it is not added.

【図2】リン酸遊離率と反応時間との関係を示す図であ
る。
FIG. 2 is a diagram showing the relationship between phosphoric acid release rate and reaction time.

【図3】本発明に係るPDP−25に含まれるフィチン
酸リン酸エステル類の高速液体クロマトグラフィーによ
るパターンを示す図である。
FIG. 3 is a diagram showing a pattern obtained by high performance liquid chromatography of phytic acid phosphates contained in PDP-25 according to the present invention.

【図4】本発明に係るPDP−30に含まれるフィチン
酸リン酸エステル類の高速液体クロマトグラフィーによ
るパターンを示す図である。
FIG. 4 is a diagram showing a pattern obtained by high performance liquid chromatography of phytic acid phosphates contained in PDP-30 according to the present invention.

【図5】本発明に係るPDP−40に含まれるフィチン
酸リン酸エステル類の高速液体クロマトグラフィーによ
るパターンを示す図である。
FIG. 5 is a diagram showing a pattern obtained by high performance liquid chromatography of phytic acid phosphates contained in PDP-40 according to the present invention.

【図6】本発明に係るPDP−50に含まれるフィチン
酸リン酸エステル類の高速液体クロマトグラフィーによ
るパターンを示す図である。
FIG. 6 is a diagram showing a pattern obtained by high performance liquid chromatography of phytic acid phosphates contained in PDP-50 according to the present invention.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】  フィチン酸又はその塩類が有するリン
酸ラジカルの数が少なくとも5以下、好ましくは2以上
5以下であるフィチン酸部分分解物又は該金属塩を主成
分とすることを特徴とするミネラル吸収促進剤。
Claim 1: A mineral characterized in that the main component is a partial decomposition product of phytic acid or a metal salt thereof, in which the number of phosphoric acid radicals contained in phytic acid or its salts is at least 5 or less, preferably 2 or more and 5 or less. Absorption enhancer.
【請求項2】  フィチン酸又はその塩類にフィターゼ
を作用させて、リン酸ラジカルが全て遊離しない範囲内
で加水分解を起させたことを特徴とするフィチン酸部分
分解物の製造方法。
2. A method for producing a partially decomposed product of phytic acid, which comprises allowing phytase to act on phytic acid or a salt thereof to cause hydrolysis within a range in which no phosphoric acid radicals are liberated.
【請求項3】  フィチン酸又はその塩類を酸性加熱下
で、更に必要に応じて加圧して、リン酸ラジカルが全て
遊離しない範囲内で加水分解を起させたことを特徴とす
るフィチン酸部分分解物の製造方法。
3. Partial decomposition of phytic acid, characterized in that phytic acid or its salts are hydrolyzed under acidic heating and, if necessary, pressurized to the extent that no phosphoric acid radicals are liberated. How things are manufactured.
【請求項4】  前記請求項第2項又は第3項に記載す
る製造方法により得られたフィチン酸部分分解物に金属
塩水溶液を添加して不溶物を除去し、一方、生成された
フィチン酸部分分解物の金属塩にアルコールを添加して
該金属塩を沈澱物として取り出し、該沈澱物を乾燥させ
て粉末にしたことを特徴とするフィチン酸部分分解物の
金属塩粉末の製造方法。
4. A metal salt aqueous solution is added to the phytic acid partially decomposed product obtained by the production method according to claim 2 or 3 to remove insoluble materials, while the produced phytic acid 1. A method for producing a powder of a metal salt of a partially decomposed phytic acid product, which comprises adding alcohol to the metal salt of the partially decomposed product, extracting the metal salt as a precipitate, and drying the precipitate to form a powder.
JP3050384A 1991-02-23 1991-02-23 Mineral absorption promoter Expired - Fee Related JP2509824B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3050384A JP2509824B2 (en) 1991-02-23 1991-02-23 Mineral absorption promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3050384A JP2509824B2 (en) 1991-02-23 1991-02-23 Mineral absorption promoter

Publications (2)

Publication Number Publication Date
JPH04270296A true JPH04270296A (en) 1992-09-25
JP2509824B2 JP2509824B2 (en) 1996-06-26

Family

ID=12857376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3050384A Expired - Fee Related JP2509824B2 (en) 1991-02-23 1991-02-23 Mineral absorption promoter

Country Status (1)

Country Link
JP (1) JP2509824B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010135588A2 (en) 2009-05-21 2010-11-25 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2397486A1 (en) 2006-09-21 2011-12-21 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
WO2019082335A1 (en) * 2017-10-26 2019-05-02 大塚製薬株式会社 Inositol phosphate-containing composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL BIOCHEMISTRY=1987 *
J.INST.BREW.=1960 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2617815A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617729A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617816A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617819A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617820A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617728A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2397486A1 (en) 2006-09-21 2011-12-21 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617817A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2620495A2 (en) 2006-09-21 2013-07-31 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617821A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2617823A2 (en) 2006-09-21 2013-07-24 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
WO2010135588A2 (en) 2009-05-21 2010-11-25 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
EP2698374A1 (en) 2009-05-21 2014-02-19 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
WO2019082335A1 (en) * 2017-10-26 2019-05-02 大塚製薬株式会社 Inositol phosphate-containing composition
US11446317B2 (en) 2017-10-26 2022-09-20 Otsuka Pharmaceutical Co., Ltd. Inositol phosphate-containing composition

Also Published As

Publication number Publication date
JP2509824B2 (en) 1996-06-26

Similar Documents

Publication Publication Date Title
JPH07114634B2 (en) Phosphopeptides and nutritional or therapeutic products
JPH02257854A (en) Phosphoropeptide and nourishing medicine composition containing it
JPH09191852A (en) Healthy food
JP2002034592A (en) Method for producing protein-zinc readily absorbable in body
WO2006101301A1 (en) Calcium binding amino acid
US5654019A (en) Bone enhancing factors from whey and compositions containing the same
CN102030817B (en) Peptide for inhibiting angiontensin converting enzyme
JPH0416165A (en) Preparation of bone-fortifying food, feed and medicine and bone peptide and protein mixture to be used therein
EP1964855B1 (en) Mineral absorption enhancer, food and feeding stuff
JP2509824B2 (en) Mineral absorption promoter
EP0791357A2 (en) Use of gluten peptides as stimulator of mineral absorption and preventive agent of hyperlipidermia and hypercholesterolemia
JP3979543B2 (en) Antiallergic agent and method for producing the same
CA2394430C (en) A calcium absorption enhancing agent and a method for producing it
CN110179127B (en) Nutrient supplement for promoting absorption of iron, zinc and calcium and preparation method thereof
JP3397258B2 (en) Calcium absorption promoting water-soluble fraction, composition containing the same, and calcium absorption promoting additive
JPH06205653A (en) Mineral sorption promotor containing lactulose oligosaccharide as active ingredient
FitzGerald et al. Caseinphosphopeptides (CPPs) as functional ingredients
CN101868475A (en) Food material for inhibiting bone resorption
JP3379198B2 (en) Food and drink promoting mineral absorption
KR100734944B1 (en) Functional food-composition with calcium lactate and rice bran
JPH05284939A (en) Beverage and food containing calcium
JPH0379979B2 (en)
JPH07228540A (en) Mineral absorbefacient and food comprising the same
JP3993907B2 (en) Calcium absorption promoter
CN1392264A (en) Process for preparing easy body absorption protein ion and health food produced therefrom

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19960123

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees